Aline Van der Vorst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aline Van der Vorst has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Weltens
Department of Oncology, University Hospitals Leuven, Leuven, Belgium
4 shared publications - Maarten Lambrecht
UZ Leuven, Leuven, Belgium
3 shared publications - Truus Reynders
Department of Radiation Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium
3 shared publications - Adinda Baten
Department of Radiotherapy Oncology, KU Leuven—University of Leuven, University Hospital Leuven, Leuven, Belgium
2 shared publications - Laurence Delombaerde
Univ Hosp Gasthuisberg, Dept Radiat Oncol, Leuven, Belgium
2 shared publications - Lucas Van Aelst
Department of Cardiology, University Hospitals Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium
2 shared publications
Latest Publications
- Open Access
- 3 June 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 59, 101209
Continuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial
- 3 June 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 59, 101209
Open AccessContinuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial
- Open Access
- 8 April 2026
- Published by Elsevier in SSRN Electronic Journal
Continuous positive airway pressure in breast cancer radiotherapy: protocol of a prospective clinical trial
BackgroundRadiotherapy (RT) improves survival and local control after breast-conserving surgery (BCS) for breast cancer (BC) but can also cause toxicity. Preliminary studies suggest that continuous positive airway pressure (CPAP) reduces organ-at-risk (OAR) doses in left-sided BC RT. This prospective trial evaluates whether CPAP reduces OAR doses in a larger patient cohort, including both left and right-sided cases, and identifies which patients benefit most. Furthermore, this study investigates the feasibility of CPAP in BC RT, by evaluating patient comfort, radiation time, accuracy and reproducibility.MethodsBC patients requiring BCS and RT are prospectively enrolled —left-sided cases with or without regional nodal irradiation (RNI), or right-sided cases requiring RNI. Each patient undergoes an additional CT simulation with CPAP—free breathing (FB) for right-sided cases and deep inspiration breath hold (DIBH) for left-sided cases. Left-sided patients unable to perform DIBH or ≥70 years old are evaluated in FB. Two RT plans (with and without CPAP) are compared. If CPAP reduces mean heart or contralateral breast dose by ≥0.5Gy, or mean lung dose by ≥1Gy, treatment is delivered with CPAP. Patient comfort is assessed through surveys. Sample size calculations indicated that 53 patients are required to detect a ≥0.5Gy reduction in mean heart dose.DiscussionThis is the first large, prospective study to evaluate CPAP in both left- and right-sided BC patients, aiming to demonstrate OAR dose reductions and assess feasibility. The final aim is to provide patient-selection models and guidelines for clinical implementation.Trial registration: The study is registered on Clinicaltrials.gov (NCT07373782).
- 8 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessContinuous positive airway pressure in breast cancer radiotherapy: protocol of a prospective clinical trial
BackgroundRadiotherapy (RT) improves survival and local control after breast-conserving surgery (BCS) for breast cancer (BC) but can also cause toxicity. Preliminary studies suggest that continuous positive airway pressure (CPAP) reduces organ-at-risk (OAR) doses in left-sided BC RT. This prospective trial evaluates whether CPAP reduces OAR doses in a larger patient cohort, including both left and right-sided cases, and identifies which patients benefit most. Furthermore, this study investigates the feasibility of CPAP in BC RT, by evaluating patient comfort, radiation time, accuracy and reproducibility.MethodsBC patients requiring BCS and RT are prospectively enrolled —left-sided cases with or without regional nodal irradiation (RNI), or right-sided cases requiring RNI. Each patient undergoes an additional CT simulation with CPAP—free breathing (FB) for right-sided cases and deep inspiration breath hold (DIBH) for left-sided cases. Left-sided patients unable to perform DIBH or ≥70 years old are evaluated in FB. Two RT plans (with and without CPAP) are compared. If CPAP reduces mean heart or contralateral breast dose by ≥0.5Gy, or mean lung dose by ≥1Gy, treatment is delivered with CPAP. Patient comfort is assessed through surveys. Sample size calculations indicated that 53 patients are required to detect a ≥0.5Gy reduction in mean heart dose.DiscussionThis is the first large, prospective study to evaluate CPAP in both left- and right-sided BC patients, aiming to demonstrate OAR dose reductions and assess feasibility. The final aim is to provide patient-selection models and guidelines for clinical implementation.Trial registration: The study is registered on Clinicaltrials.gov (NCT07373782).
- 20 February 2025
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 201 (4) , 368-382
Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention
Background Breast cancer is the most prevalent cancer in women worldwide; nevertheless, the prognosis is good, with a 5-year overall survival of 80–90%. Therefore, it becomes crucial to strive for high quality of life after cure by minimizing treatment-related toxicity. One such concern is radiation-induced heart disease, which remains a significant focus of ongoing investigations. Purpose The aim of this review is to summarize current knowledge on radiation-induced heart disease in breast cancer patients by giving an overview of its epidemiology, risk factors, radiation parameters related to its development, solutions in radiation practice, and prevention. The goal is to raise awareness and maximize prevention of radiation-induced heart disease. Methods The PubMed database was screened for articles published between January 2013 and November 2023 related to the keywords , , , and . Moreover, by screening the literature lists of these publications, additional articles were added. Results Ninety-four relevant papers remained for final review. Conclusion Radiation-induced heart disease is a rare complication after breast cancer radiotherapy and represents a clinical spectrum of various cardiovascular conditions. Several heart-sparing techniques have been developed, and more attention has been paid to early diagnosis and prevention of radiation-induced heart disease. However, further research remains important to refine radiotherapy techniques and deepen our understanding for improved prevention and treatment of this condition in the future. This clinical review summarizes the existing evidence and literature on radiation-induced heart disease following modern breast cancer radiotherapy, offering clinical guidance for physicians.
- 20 February 2025
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 201 (4) , 368-382
Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention
Background Breast cancer is the most prevalent cancer in women worldwide; nevertheless, the prognosis is good, with a 5-year overall survival of 80–90%. Therefore, it becomes crucial to strive for high quality of life after cure by minimizing treatment-related toxicity. One such concern is radiation-induced heart disease, which remains a significant focus of ongoing investigations. Purpose The aim of this review is to summarize current knowledge on radiation-induced heart disease in breast cancer patients by giving an overview of its epidemiology, risk factors, radiation parameters related to its development, solutions in radiation practice, and prevention. The goal is to raise awareness and maximize prevention of radiation-induced heart disease. Methods The PubMed database was screened for articles published between January 2013 and November 2023 related to the keywords , , , and . Moreover, by screening the literature lists of these publications, additional articles were added. Results Ninety-four relevant papers remained for final review. Conclusion Radiation-induced heart disease is a rare complication after breast cancer radiotherapy and represents a clinical spectrum of various cardiovascular conditions. Several heart-sparing techniques have been developed, and more attention has been paid to early diagnosis and prevention of radiation-induced heart disease. However, further research remains important to refine radiotherapy techniques and deepen our understanding for improved prevention and treatment of this condition in the future. This clinical review summarizes the existing evidence and literature on radiation-induced heart disease following modern breast cancer radiotherapy, offering clinical guidance for physicians.
- Open Access
- 22 November 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 32, 100677
Pro-active risk analysis of an in-house developed deep learning based autoplanning tool for breast Volumetric Modulated Arc Therapy
- 22 November 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 32, 100677
Open AccessPro-active risk analysis of an in-house developed deep learning based autoplanning tool for breast Volumetric Modulated Arc Therapy
- Open Access
- 18 April 2022
- Published by Elsevier in The Breast
- Vol. 64, 29-34
Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer
- 18 April 2022
- Published by Elsevier in The Breast
- Vol. 64, 29-34
Open AccessValidation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer